DV
Dividend Vision

DMAC — DiaMedica Therapeutics Inc

DiaMedica Therapeutics Inc (DMAC)

Total return is 414.3% over the past 18.6 years, 257.0 points behind SPY at 671.3%. Its deepest 1-year drawdown was 43.2%.

DMAC is a single-stock equity holding in DiaMedica Therapeutics Inc, a biomedical company. The holding carries no dividend distribution or associated yield, and expense ratio data is not available. This security appeals primarily to investors seeking equity exposure to the healthcare/therapeutics sector rather than those focused on dividend income.

DMAC key facts

Asset type
Stock
Asset class
Equity
Inception date
01/04/2008
Last close
$6.68
Market cap
$393,348,416
Average volume
165178.0
Payment date
11/15/2018
Beta
0.967
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.71